|Publication number||US3901402 A|
|Publication date||Aug 26, 1975|
|Filing date||May 31, 1974|
|Priority date||Mar 14, 1973|
|Publication number||US 3901402 A, US 3901402A, US-A-3901402, US3901402 A, US3901402A|
|Inventors||Ayres Waldemar A|
|Original Assignee||Becton Dickinson Co|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (5), Referenced by (32), Classifications (45)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent 1 1 1111 3,901,402
Ayres Aug. 26, 1975 STOPPER-PISTON 3,810,469 Y 5/1974 Hurschman 128/DIG. 2s
 Inventor: Waldemar A. Ayres, Rutherford, FOREIGN PATENTS OR APPLICATIONS NJ. 1,255,197 l/l961 France 215/307  Assignee: Becton, Dickinson and p y 982,744 2/1965 United Kmgdom 215/307 East Rutherford, NJ. I Primary ExaminerRichard A. Gaudet Filed! 31, 1974 Assistant ExaminerI-Ienry J. Recla ] Appl NO; 475,044 [SIZE "16y, Agelrzt, 0r FirmKane, Dalsimer, Kane,
u 1van an urucz Related US. Application Data  Division of Ser. No. 341,044, March 14, 1973, Pat.  ABSTRACT An assembly adapted to receive blood for separation into a light liquid phase of serum or plasma and a  heavy phase is disclosed. The assembly includes a self- [511 Int Cl 2 B65D 51/16 sealing, pierceable, elastomeric stopper-piston mem- Fie'ld 272 218 P her which is capable of acting as a slidable piston as 122N218 PA 28 1 1 well as a closure for holding a vacuum in an evacuated 233/26.'23/258 230 container for collecting blood. Means is provided which is capable of pushing the piston member downwardly in the container; the means having a pointed  References Cited tubular member associated therewith which is capable UNITED STATES PATENTS of piercing the piston so as to provide a passage for 2,649,090 8/1953 Parsons et a1 128/272 condu ting the separated light liquid phase from one 3 1 7 3 side of the stopper-piston to the other side thereof. g e 3,695,478 10 1972 Sie a a]. 128/272 6 Clmms, 8 Drawmg Flgures PAIENTEU AUBZBIQYS SHEET 2 L? STOPPER-PISTON This is a division of application Ser. No. 341,044 filed Mar. 14, 1973, now US. Pat. No. 3,850,174.
BACKGROUND OF THE INVENTION The present invention relates to an assembly for the separation of blood into its component phases of serum or plasma and cellular or solid phase. Various devices are known and are used for separating blood into its component phases. It is clinically desirable to isolate the liquid phase from the solid phase of blood to prevent chemical interaction between the separated cellular portion and the plasma or serum. Several of the devices presently used are disclosed in US. Pat. Nos. 3,355,089; 3,481,477; 3,508,653 and 3,512,940.
The present invention proposes to improve upon these devices which are used for the separation of blood into its component phases.
SUMMARY OF THE INVENTION The invention generally contemplates the provision of an assembly adapted to receive blood for separation into a light liquid phase of serum or plasma and a heavy phase. The assembly includes a self-sealing pierceable, elastomeric stopper-piston member which is capable of acting as a slidable piston as well as a closure for holding a vacuum in an evacuated container for collecting blood.
Means is provided which is capable of pushing the stopper-piston downwardly into the container while at the same time a pointed tubular member associated with the means penetrates the stopper-piston to form a passageway therethrough to permit the plasma-serum to be conducted through the passageway thereby enabling the stopper-piston to be moved downwardly through the light phase to just above the heavy phase of blood. After the downward movement of the stopper-piston is completed the pointed tubular member is removed from the self-sealing pierceable stopperpiston to form an impermeable barrier between the light phase and the heavy phase of blood.
It is an object of the invention to provide a stopperpiston which is capable of closing the open end of a blood collection container and seals the container to maintain a vacuum therein.
Another object of the invention is to provide a serum-plasma separator assembly having a selfcontained slidable member which will act as a closure element prior to use and a piston when in use.
Another object of the invention is to provide an assembly for separating the serum-plasma phase from the cellular phase said assembly including a blood container, a stopper-piston and a sealing cap, whereby the serum plasma is contained in a first chamber including the blood container, the stopper-piston and the sealing cap, and the cellular phase being contained in a second and separate chamber including the blood container and the stopper-piston so that the container can be inverted, handled roughly or shipped without spilling any of the contents or without remixing the serum-plasma and cellular phases.
DESCRIPTION OF THE DRAWINGS FIG. 1 is a compressed elevational and partially sectional view of the blood collection assembly fitted with the stopper piston of the invention herein and a cap for sealing the tube prior to use.
FIG. 2 is a sectional elevational view of the stopper piston.
FIG. 3 is a bottom view of the stopper piston as shown in FIG. 1.
FIG. 4 is a sectional elevational view of a cap for enclosing the stopper piston as in FIG. 1 and for closing the open end of the collection container as illustrated in FIG. 8.
FIG. 5 is a sectional elevational view of the blood collection assembly illustrated in FIG. 1 prior to inserting the piston-closure all the way into the open end of the container.
FIG. 6 is an elevational sectional view which illustrates the collection of blood using the device of FIG. 1.
FIG. 7 is an elevational sectional view of the assembly of FIG. 1 in which the stopper-piston has been moved downwardly through the separated liquid phase.
FIG. 8 is an elevational sectional view of the blood collection container after the serum or plasma has been separated from the cellular phase and the means for pushing the piston to the interface has been removed and the cap (of FIG. 4) has been placed over the upper end of the blood container tube to seal in the light phase of the blood.
DESCRIPTION OF THE PREFERRED EMBODIMENTS For a better understanding of the invention reference is had to the drawings which illustrate the various elements of the blood collection and separator assembly. In FIG. 1 a blood collection assembly 10 includes a blood collection container 12 generally made of a transparent material such as glass or a transparent plastic material which is inert to blood or any of its components, anticoagulants or other chemicals used in connection with the collection, storage or analysis of blood.
Stopper-piston 14 is removably mounted in the open end of container 12 and provides an interference fit capable of maintaining a vacuum until the blood sample is collected. A cap 16 which is designed to enclose the stopper-piston end of the collection container is provided to maintain sterility of the exposed outer surface 15 of stopper-piston 14 until the device is used. Cap 16 is molded as a unitary structure and is preferably formed of a material which is capable of being pierced by a pointed tubular member and is sufficiently elastic to provide a compression fit when mounted in position as seen in FIG. 1. Cap 16 may be made of an elastomeric material, such as rubber, natural or synthetic. Attached to the closed end 17 of cap 16 is skirt 18. Skirt 18 is formed having a concave surface 19 and is sufficiently deformable to provide a compression fit to hold cap 16 in place as seen in FIG. 1.
Stopper-piston 14 is made of a self-sealing, pierceable, elastomeric material inert to and unaffected by blood or other parenteral fluids and chemicals associated with the collection thereof. Examples of such a material may be natural or synthetic rubber. Stopper piston 14 includes a tubular body portion 11 having a diameter slightly smaller than the internal diameter of container 12. A plurality of sealing rings 22 is integrally formed with body portion 11, the sealing rings having a diameter slightly greater than the internal diameter of container 12'so that when body portion 11 is inserted into container 12 the sealing rings exert compressive forces against the inner wall of container 12 sufficient to hold and maintain a vacuum prior to the collection of blood. I
Stopper-piston 14 is formed having an enlarged solid top rim portion 13 integrally formed with the upper end of a tubular body portion 11. The diameter of top rim portion 13 is greater than body portion 11 and substantially equal to the external diameter of container 12. Rim portion 13 is resilient and is capable of flexing when a sufficient force is applied to stopper-piston 14 as illustrated in FIG. 7. Body portion 11 of stopperpiston 14 is trilobal and each lobe 23 is separated by a venting channel 20. Base 21 of each channel is beveled inwardly to provide additional elastomeric material to support and reinforce lowest seal ring 22. The base 21 of channel 20 is preferably pitched at about 45 with the lobes 23 preferably spaced about 120 apart. When container 12 is being evacuated channels 20 provide air passages to permit air to escape while stopper-piston 14 has been inserted part way into container 12, as shown in FIG. 5. Also, since stopper-piston 14 is trilobal rather than bilobal, stopper-piston 14 has less tendency to become tilted or cocked as it is being moved into container 12 to engage sealing rings 22. Since stopperpiston 14 remains in substantial axial alignment with container 12 maximum contact is achieved between seal rings 22, the top rim 18 and the inner wall surfaces of container 12. This prevents any loss of vacuum or later any remixing of light phase liquid and heavy phase around stopper-piston 14. When stopper-piston 14 is at its initial position, as in FIGS. 1 and 6, rim portion 18 prevents stopper-piston 14 from sliding into container 12 as tubular member 46 is inserted, even though container 12 has been evacuated. In this connection, rim 18 rests on the top edge surface of container 12 and helps prevent stopper-piston 14 from sliding prematurely into container 12.
FIG. 4 illustrates a form of a closure cap 16 designed and employed to maintain the top surface portion of stopper-piston 14 in aseptic condition prior to the filling of blood in collection container 12. Cap 16 is made of a resilient material which is capable of being penetrated by a pointed tubular member 34 as illustrated in FIG. 6. During the blood collection step, cap 16 is either removed or is not removed from the assembly as preferred. If not removed, during this procedure, the pointed tubular member pierces cap 16 and then stopper-piston 14, the force of the needle penetration being insufficient added force to cause stopper-piston 14 to be pushed into container 12. After the blood is collected the collection assembly is ready for processing.
FIG. 7 illustrates blood collection assembly 10 with stopper-piston 14 moved toward the blood cell and plasma interface by employing a pusher element or member 30. Pusher 30 is elongated and has a shaft 31 and a finger engaging head portion 32 at its upper or outer end. A pointed tubular member 34 is mounted at the lower or inner end of shaft 31. The lower end of shaft 31 is formed having a longitudinally extending slot 35 having a diameter sufficient to mount tubular element 34 therein. Tubular element 34 is fitted into a hub 33 and is rigidly mounted within slot 35. The pointed end 37 of tubular member 34 is capable of piercing stopper-piston 14. As illustrated in FIG. 7, tubular member 34 has pierced stopper-piston 14 to form a passage therethrough so as to conduct plasma P through stopper-piston 14 through its exit opening 38 at the other end of tubular member 34 so that plasma P becomes separated from the cellular portion C in container 12. After pusher member 30 has moved stopper-piston 14 to a location adjacent the blood cellplasma/serum interface 50, pusher 30 is removed and piston 14 seals itself and a permanent barrier is thereby formed between cells C and plasma P, as illustrated in FIG. 8.
For a better understanding of practicing the invention herein reference is had to FIGS. 6, 7 and 8. When a blood sample is to be collected in the blood collection assemby of FIG. 1 a blood collecting apparatus such as is disclosed in US. Pat. No. 2,460,641 may be employed.
As shown in FIG. 6, the apparatus includes a holder 40 open at one end and closed at the other end. The closed end is formed having a threaded passageway 42 for receiving a threaded hub 44 supporting tubular member 46. The tubular member 46 is mounted in hub 44 intermediate its ends 47 and 48. Ends 47 and 48 are pointed and are capable of piercing a vein V and stopper-piston 14 and cap 16 as depicted in FIG. 6. After pointed end 48 has punctured vein V, blood collection assembly 10 is pierced by pointed end 47 of tubular member 46 so that a blood sample is sucked into evacuated tube 12. After the blood sample is collected assembly 10 is removed from holder 40 and is then processed for chemical testing in the usual manner, such as by centrifuging to separate the serum or plasma from the cellular phase.
Then pointed tubular member 34 mounted on pusher 30 is pushed downwardly until it pierces stopper-piston 14. With tubular member 34 in position a passage from the lower side of stopper-piston 14 to the upper side is provided. Then by exerting downward pressure on pusher 30 and by moving the stopper-piston 14 downwardly the plasma or serum is conducted through tubular element 34 and is stored on the upper surface 15 of stopper-piston 14. When pointed end 37 of tubular member 34 and the stopper-piston 14 approach the blood interface 50 the downward force is stopped and pusher 30 is pulled out of stopper-piston 14 so that a permanent barrier is formed between the plasma on one side of stopper-piston l4 and the cells on the other. The plasma is then ready for testing in the usual manner.
In FIG. 8, blood collection assembly 10 is illustrated with stopper-piston 14 adjacent the blood interface 50. Cap 16 is mounted over the open end of blood collection container 12. The blood collection assembly 10 can then be stored, transported or can be used to obtain samples of plasma or serum to perform various tests. Further, the blood collection assembly in the form illustrated in FIG. 8 can be shipped for subsequent testing at a different laboratory or facility.
It is apparent that the several objects of the invention as set forth herebefore have been accomplished and it is obvious that numerous changes in structures or the steps required for practicing the invention can be employed without departing from the invention as defined in the claims.
What is claimed is:
l. A stopper-piston made of a self-sealing, elastomeric, pierceable material adapted to seal the open end of a blood collection container and capable of maintaining a vacuum therein prior to the collection of a blood sample, said stopper-piston comprising:
a tubular body portion including sealing means positioned between the ends thereof and integrally formed thcrearound;
said sealing means adapted to exert sufficient compressive forces against the inner wall of the collec- 5 tion container so as to hold a vacuum;
a top surface formed at one end of said tubular body portion and capable of being pierced by a pointed tubular member;
said top surface extending beyond said body portion to form a rim which is deformable and provides a second sealing means when the stopper-piston is pushed into said container to function as a piston; and said rim has a diameter substantially equal to the external diameter of said container;
said body portion having at least three lobes formed at said other end so that when said stopper-piston is mounted in the open end of said blood collection container said lobes will compress inwardly toward the axis of the stopper-piston to provide supporting contact areas to maintain the stopper-piston in axial alignment when an axial force is exerted against the piston to move the piston into the container.
2. The stopper-piston of claim 1 wherein the sealing means includes a plurality of circumferentially spaced rings integrally formed between ends of said body portron.
3. The stopper-piston of claim 2 wherein said other end of said body portion is formed having three lobes.
4. The stopper-piston of claim 3 wherein said three lobes are separated each lobe being further separated by a venting channel, the sides of which are defined by the end surfaces of adjacent lobes, the base of said venting channel being inclined with respect to the longitudinal axis of said body portion.
5. The stopper-piston of claim 4 wherein the base of said venting channel is inclined 45; the upper and outer edge portion of which terminates adjacent the lowermost sealing ring formed on said body portion.
6. The stopper-piston of claim 1 wherein a venting means is formed in said body portion, said venting means being positioned between adjacent lobes.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2649090 *||Sep 29, 1950||Aug 18, 1953||American Cyanamid Co||Rubber closure for pharmaceutical vials|
|US3366103 *||Jun 24, 1965||Jan 30, 1968||Becton Dickinson Co||Blood collecting assembly|
|US3378008 *||Jul 23, 1965||Apr 16, 1968||Min I Jet Corp||Hypodermic syringe with vial|
|US3695478 *||Aug 10, 1970||Oct 3, 1972||Post Hendrik Alle||Flexibly deformable stopper for a hypodermic syringe|
|US3810469 *||May 24, 1972||May 14, 1974||Ampoules Inc||Multiple compartment hypodermic devices|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4020831 *||Dec 4, 1975||May 3, 1977||Technicon Instruments Corporation||Blood collecting syringe|
|US4193402 *||Feb 2, 1979||Mar 18, 1980||Rumpler Jean Jacques||Bottle stopper and method of using said stopper|
|US4204606 *||Nov 1, 1977||May 27, 1980||Dematex Development & Investment Establishment||Tube and stopper combination with venting structure|
|US4355111 *||May 28, 1980||Oct 19, 1982||Terumo Corporation||Microorganism culturing device|
|US4369117 *||May 12, 1980||Jan 18, 1983||American Hospital Supply Corporation||Serum separating method and apparatus|
|US4373646 *||May 14, 1981||Feb 15, 1983||Phillips Petroleum Company||Cartridge-type dispenser|
|US4443345 *||Jun 28, 1982||Apr 17, 1984||Wells John R||Serum preparator|
|US4703763 *||Jun 17, 1985||Nov 3, 1987||Sherwood Medical Company||Blood sample syringe|
|US4730624 *||Aug 22, 1983||Mar 15, 1988||Becton, Dickinson And Company||Device and method for drawing a blood sample|
|US4811866 *||Jan 2, 1987||Mar 14, 1989||Helena Laboratories Corporation||Method and apparatus for dispensing liquids|
|US5037399 *||Jul 7, 1989||Aug 6, 1991||Reichert Elmer L||Apparatus for the administration of medications to animals|
|US5076280 *||Feb 9, 1989||Dec 31, 1991||Terumo Kabushiki Kaisha||Device for correcting blood pressure waveform|
|US5203825 *||Jun 7, 1991||Apr 20, 1993||Becton, Dickinson And Company||Capillary tube assembly including a vented cap|
|US5257529 *||Mar 8, 1993||Nov 2, 1993||Nissho Corporation||Method and device for measurement of viscosity of liquids|
|US5752940 *||Apr 8, 1996||May 19, 1998||Becton Dickinson And Company||Syringe and method for lyophilizing and reconstituting injectable medication|
|US5795337 *||Apr 10, 1996||Aug 18, 1998||Becton Dickinson And Company||Syringe assembly and syringe stopper|
|US6423037 *||Nov 27, 1998||Jul 23, 2002||Kaken Pharmaceutical Co., Ltd.||Reduced-pressure syringe and manufacturing method therefor|
|US7674246||Mar 9, 2010||West Pharmaceutical Services Of Delaware, Inc.||Automatic injection and retraction syringe|
|US7758548||Jul 20, 2010||West Pharmaceutical Services Of Delaware, Inc.||Coupling for an auto-injection device|
|US7988675||Jan 31, 2007||Aug 2, 2011||West Pharmaceutical Services Of Delaware, Inc.||Automatic injection and retraction devices for use with pre-filled syringe cartridges|
|US8123724||Jul 18, 2006||Feb 28, 2012||West Pharmaceutical Services Of Delaware, Inc.||Auto-injection syringe having vent device|
|US8444620 *||Jul 8, 2010||May 21, 2013||Biomet Biologics, Llc||Method and apparatus for application of a fluid|
|US9028457||May 21, 2013||May 12, 2015||Biomet Biologics, Llc||Method and apparatus for application of a fluid|
|US9211487||Aug 26, 2013||Dec 15, 2015||Biomet Biologics, Llc||Sterile blood separating system|
|US20060178629 *||Dec 8, 2005||Aug 10, 2006||Pharma-Pen Holdings, Inc.||Coupling for an auto-injection device|
|US20060178631 *||Dec 8, 2005||Aug 10, 2006||Pharma-Pen Holdings, Inc.||Automatic injection and retraction syringe|
|US20060178642 *||Dec 8, 2005||Aug 10, 2006||Pharma-Pen Holdings, Inc.||Breech loaded fixed needle syringe and automatic injection device having the same|
|US20070078394 *||Jul 18, 2006||Apr 5, 2007||Gillespie Iii Richard D||Auto-Injection Syringe Having Vent Device|
|US20070135767 *||Jan 31, 2007||Jun 14, 2007||Gillespie Richard D Iii||Automatic injection and retraction devices for use with pre-filled syringe cartridges|
|US20100274206 *||Jul 8, 2010||Oct 28, 2010||Biomet Manufacturing Corp.||Method and Apparatus for Application of a Fluid|
|WO2006063172A2 *||Dec 8, 2005||Jun 15, 2006||West Pharmaceutical Services, Inc.||Breech loaded fixed needle syringe and automatic injection device having the same|
|WO2006063172A3 *||Dec 8, 2005||Jul 27, 2006||Pharma Pen Holdings Inc||Breech loaded fixed needle syringe and automatic injection device having the same|
|U.S. Classification||215/248, 210/800, 604/218, 604/88, 215/307, 600/577, 210/516|
|Cooperative Classification||A61B5/150389, A61B5/15003, A61B5/150236, A61B5/150274, B01L2300/0672, A61B5/1438, B01L3/50215, A61B5/150496, A61B5/150244, A61B5/150221, A61B5/150351, A61B5/150755, A61B5/150732, A61B5/154, G01N33/491, A61J1/05, B01L3/50825, A61J1/1406, A61B5/150213, B01L2400/0478, B01L2200/0689|
|European Classification||G01N33/49C, A61B5/15B8J, A61B5/15B12, B01L3/50825, A61B5/15B26, B01L3/50215, A61B5/15B8H, A61B5/154, A61B5/15B8B, A61B5/15B18B2, A61B5/15B18B8F, A61B5/15B8D, A61B5/15B20, A61B5/15B2D, A61B5/15B8R, A61B5/14B12|